Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of the American Chemical Society|April 13, 2010
An alternative approach to aldol reactions: gold-catalyzed formation of boron enolates from alkynesCindy Körner, Pavel Starkov, Tom D Sheppard
The Journal of Biological Chemistry|February 1, 2013
MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCepsilon)Cindy Körner, Ioanna Keklikoglou, Christian Bender, et al.
Cancers|May 16, 2023
A Tumor Microenvironment-Driven Network Regulated by STAT3 and p65 Negatively Controls the Enrichment of Cancer Stem Cells in Human HR+/HER2- Breast CancerHagar Ben-Yaakov, Tsipi Meshel, Metsada Pasmanik-Chor, et al.
NAR Cancer|July 28, 2021
On the impact of batch effect correction in TCGA isomiR expression dataSusanne Ibing, Birgitta E Michels, Moritz Mosdzien, et al.
BMC Genomics|August 10, 2016
The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migrationOmar Salem, Nese Erdem, Janine Jung, et al.
Frontiers in Immunology|April 30, 2019
Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast CancerYulia Liubomirski, Shalom Lerrer, Tsipi Meshel, et al.
Journal of Leukocyte Biology|March 4, 2016
Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumorsPolina Weitzenfeld, Olga Kossover, Cindy Körner, et al.
Frontiers in Immunology|May 30, 2017
Co-Inflammatory Roles of TGFβ1 in the Presence of TNFα Drive a Pro-inflammatory Fate in Mesenchymal Stem CellsShalom Lerrer, Yulia Liubomirski, Alexander Bott, et al.
Frontiers in Immunology|May 21, 2019
Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast CancerYulia Liubomirski, Shalom Lerrer, Tsipi Meshel, et al.
Molecular Oncology|June 6, 2026
PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer modelLuisa Schwarzmüller, Janina Müller, Efstathios-Iason Vlachavas, et al.
Pageof 2